Candel Therapeutics (CADL) DMA 200 (2022 - 2026)

Candel Therapeutics (CADL) DMA 200 (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) DMA 200
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 3.91
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 135.28
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 8.38
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 25.77
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 16.79
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - 4.44
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 9.96
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 437.41
9 Abivax 94.37 Bn 94.37 Bn - 110.18
10 Candel Therapeutics 449.62 Mn 449.62 Mn - 5.79

Historic Data

Download Data
DateValue
Jun 8, 2026 5.79
Jun 5, 2026 5.78
Jun 4, 2026 5.76
Jun 3, 2026 5.75
Jun 2, 2026 5.73
Jun 1, 2026 5.72
May 29, 2026 5.71
May 28, 2026 5.70
May 27, 2026 5.69
May 26, 2026 5.68
May 22, 2026 5.67
May 21, 2026 5.66
May 20, 2026 5.65
May 19, 2026 5.64
May 18, 2026 5.64
May 15, 2026 5.63
May 14, 2026 5.62
May 13, 2026 5.61
May 12, 2026 5.60
May 11, 2026 5.59